Glenmark Pharma gets sANDA nod for Abiraterone Acetate Tablets USP, 500 mg

Glenmark Pharma gets sANDA nod for Abiraterone Acetate Tablets USP, 500 mg

by admin- Friday, May 20th, 2022 03:44:49 PM

Glenmark Pharmaceuticals Inc., USA (Glenmark) received final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 500 mg, the frequent model of Zytiga 1 Tablets, 500 mg, of Janssen Biotech Inc.

News Updates